Merck revenues miss mark as diabetes, arthritis drugs lag

(Reuters) - Merck & Co Inc's quarterly revenue fell short of Wall Street expectations as the stronger dollar cut sales of its consumer and animal health products and hurt results for prescription drugs, including diabetes treatment Januvia.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news